BV
BrightView Holdings, Inc.
BV offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over BV overall, supported by stronger fundamentals and stronger modeled upside.
BV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Under pressure |
BV's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BV PE Valuation
BV has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect BV's earnings to decline, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CAT has the edge over BV on the outlook, with more favorable earnings and revenue expectations.
BV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.60 | — |
| Q3 2026 | -$0.37 | -385% |
| Q2 2026 | -$0.16 | -233% |
| Q1 2026 | $0.02 | -71% |
| Q4 2025 | $0.07 | -74% |
| Q3 2025 | $0.13 | -35% |
| Q2 2025 | $0.12 | -7.7% |
| Q1 2025 | $0.07 | -67% |
| Q4 2024 | $0.27 | +$0.46 |
BV has swung to a loss: it lost $0.37 per share over the past year, after a profit the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over BV on earnings quality, reporting a profit while its opponent remains loss making.
BV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $677.3M | -3.6% |
| Q2 2026 | $717.6M | +1.3% |
| Q1 2026 | $702.9M | +6.1% |
| Q4 2025 | $614.7M | +2.6% |
| Q3 2025 | $702.8M | -3.6% |
| Q2 2025 | $708.3M | -4.1% |
| Q1 2025 | $662.6M | -1.5% |
| Q4 2024 | $599.2M | -4.4% |
BV's revenue grew through 2021 and has held roughly level since: $677M last quarter, down 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -2.9 points |
| Q2 2026 | 4.5% | -3.6 points |
| Q1 2026 | 2.3% | -1.1 points |
| Q4 2025 | -1.2% | -1.1 points |
| Q3 2025 | 7.8% | +0.7 points |
| Q2 2025 | 8.1% | +1.5 points |
| Q1 2025 | 3.4% | -5.9 points |
| Q4 2024 | -0.1% | +0.9 points |
BV's operating margin was 5% last quarter, down 2.9 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over BV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BV on profitability, with a higher operating margin.
BV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.2M | -61% |
| Q2 2026 | -$19.3M | +$28.5M |
| Q1 2026 | -$12.6M | -122% |
| Q4 2025 | -$18.6M | -1133% |
| Q3 2025 | $26M | +23% |
| Q2 2025 | -$47.8M | -348% |
| Q1 2025 | $57.6M | -19% |
| Q4 2024 | $1.8M | -89% |
BV's free cash flow was −$40M over the past year, against $38M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over BV on cash generation, producing positive trailing cash flow while its opponent burns cash.
BV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +402K shares |
| 1 year | -3.1% | -3M shares |
| 3 years | +0.1% | +82K shares |
| 5 years | -9.8% | -10.2M shares |
BV has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $14.1M |
| Q2 2026 | $9.6M |
| Q1 2026 | $14.4M |
| Q4 2025 | $18.8M |
| Q3 2025 | $9.7M |
| Q2 2025 | $7.7M |
| Q1 2025 | $1.7M |
| Q4 2024 | $5.1M |
BV spent $57M buying back its own shares over the past year, up 135% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.1x | Elevated |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.4x | Moderate |
| Q1 2025 | 2.4x | Moderate |
| Q4 2024 | 2.3x | Moderate |
BV's net debt is about 3.1 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over BV on leverage, with a lower net debt burden relative to earnings.
BV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 38.6 | Neutral |
BV's weekly RSI is 38 (neutral) and its Stochastic is 39 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BV PE vs Industrials Sector
| Metric | BV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BV has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 4.8% below |
| 20 week MA | $11.8 | 13% below |
| 50 week MA | $12.4 | 17% below |
| 100 week MA | $13.4 | 23% below |
| 200 week MA | $11.8 | 13% below |
BV is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BV on trend strength, trading above more of its moving averages.
BV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $14.9 | -11% |
| 2021 | $14.9 | $14.0 | -6.4% |
| 2022 | $14.0 | $6.65 | -52% |
| 2023 | $6.65 | $8.42 | +27% |
| 2024 | $8.42 | $16.0 | +90% |
| 2025 | $16.0 | $12.9 | -20% |
| 2026 YTD | $12.9 | $10.3 | -20% |
BV has finished lower in four of the last six years. It's down 20% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BV on returns for 2026, with the stronger performance.